alexa Enhancement Of Cell Cycle Inhibition Effect Of Cetuximab By Using Stabilized-silver Solution In Lung Cancer Cells
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

JOINT EVENT:19th Euro Congress on Cancer Science and Therapy & 25th Cancer Nursing & Nurse Practitioners Conference
July 17-19, 2017 Lisbon, Portugal

Aysun Ozkan and Ayse Erdogan
Akdeniz University, Turkey
Posters & Accepted Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956-C1-106
This study aimed to evaluate the expression levels of topoisomerase alpha and cyclin1 and 2 in parental (P-H1299) and epirubicin resistant (R-H1299) lung cancer cells. These cells were treated with cetuximab (C225, Erbitux, a chimeric anti-epidermal growth factor receptor (EGFR) monoclonal antibody) alone and combined with stabilized-silver (St-Ag) ion solution. Total cellular RNA was isolated by RNeasy mini kit (Qiagen) after cetuximab alone and combined with St-Ag ion solution treatment for 72 hours. Total RNA was reverse-transcribed into cDNA by using Titan One Tube RT-PCR system kit. Two μl of the cDNA was used for the PCR reaction as templates. The PCR was performed in 30 cycles of denaturation at 94ºC for 1 min, annealing at 55ºC for 1 min and extension at 72ºC for 2 min. The resulting PCR products were analyzed by 2.5% agarose gel electrophoresis. Adobe photoshop CS4 program was used for band density analyzing. Cetuximab with St-Ag ion solution treatment was found more effective than cetuximab alone treatment in decreasing topoisomerase alpha (except in R-H1299 cells) and cyclin1 and 2 expressions in both cells according to control cells. Combine treatment caused more arrest in G1-phase of the cell cycle in these cells. In this study, we demonstrated that cetuximab alone and combine with St-Ag ion solution could exhibit potent anticancer activity by arresting the cell cycle in lung cancer cells. Our study may provide a reason for future clinical investigations of cetuximab combination therapy for growth control of lung cancer.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version